|
[1]
|
Shi, Q., et al. (2020) SSH3 Promotes Malignant Progression of HCC by Activating FGF1-Mediated FGF/FGFR Pathway. European Review for Medical and Pharmacological Sciences, 24, 11561-11568.
|
|
[2]
|
Ziogas, I. and Tsoulfas, G. (2017) Advances and Challenges in Laparoscopic Surgery in the Management of Hepatocellular Carcinoma. World Journal of Gastrointestinal Surgery, 9, 233-245. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Zeng, H., et al. (2018) Changing Cancer Survival in China during 2003-15: A Pooled Analysis of 17 Population-Based Cancer Registries. The Lancet Global Health, 6, e555-e567. [Google Scholar] [CrossRef]
|
|
[4]
|
Huang, Z., et al. (2012) Long-Term Outcomes of Repeat Hepatic Resection in Patients with Recurrent Hepatocellular Carcinoma and Analysis of Recurrent Types and Their Prognosis: A Single-Center Experience in China. Annals of Surgical Oncology, 19, 2515-2525. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Neumann, U. (2011) Outcome after Partial Hepatectomy for Hepatocellular Cancer within the Milan Criteria. The British Journal of Surgery, 98, 1300-1301. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Yang, J., et al. (2019) A Global View of Hepatocellular Carcinoma: Trends, Risk, Prevention and Management. Nature Reviews. Gastroenterology & Hepatology, 16, 589-604. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Gerdes, J., et al. (1983) Production of a Mouse Monoclonal Antibody Reactive with a Human Nuclear Antigen Associated with Cell Proliferation. International Journal of Cancer, 31, 13-20. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
廖谦和, 等. 子宫颈癌及癌前病变HPV16、Ki-67的表达及其相关性[J]. 临床与实验病理学杂志, 2007(3): 297-299.
|
|
[9]
|
原发性肝癌诊疗规范(2019年版) [J]. 中国临床医学, 2020, 27(1): 140-160.
|
|
[10]
|
吴孟超, 等. 原发性肝癌规范化病理诊断指南(2015年版) [J]. 临床肝胆病杂志, 2015, 31(6): 833-839.
|
|
[11]
|
何旭昶, 等. 微血管侵犯分级对肝细胞癌行根治性肝切除术后早期复发的预测价值[J]. 临床肝胆病杂志, 2020, 36(8): 1757-1762.
|
|
[12]
|
李彦龙, 张媛, 王逢茂. 术前CT征象对孤立性肝癌微血管侵犯及术后早期复发的预测分析[J]. 中国CT和MRI杂志, 2021, 19(1): 113-116.
|
|
[13]
|
夏勇, 杨田, 王葵. 肝细胞癌肝切除术后复发预防和治疗中国专家共识(2020版) [J]. 中国实用外科杂志, 2021, 41(1): 20-30.
|
|
[14]
|
Lim, M., et al. (2011) Predictable Factors for Lymph Node Metastasis in Early Gastric Cancer-Analysis of Single Institutional Experience. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract, 15, 1783-1788. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
崔凯, 张利平. p16蛋白、Ki67抗原检测在宫颈上皮内瘤变中的诊断价值[J]. 检验医学与临床, 2019, 16(24): 3704-3706.
|
|
[16]
|
贺红梅, 等. IMP3、P16、HE4、Ki67、P53在卵巢浆液性肿瘤中表达的生物学意义、鉴别诊断及预后的研究[J]. 临床和实验医学杂志, 2020, 19(23): 2537-2540.
|
|
[17]
|
李文华, 张莹. 乳腺癌复发转移灶与原发灶中ER、PR、HER-2、p53、Ki-67的表达差异[J]. 临床与实验病理学杂志, 2016, 32(7): 727-730.
|
|
[18]
|
齐兴峰, 等. 食管癌组织中Ki-67和VEGF的表达及其与放疗预后的关系[J]. 临床合理用药杂志, 2019, 12(34): 44-46+48.
|
|
[19]
|
王娜, 等. NEDD9、Ki67、P53联合检测对胃癌的早期诊断和恶性程度评估的价值[J]. 实用医学杂志, 2017, 33(12): 1961-1965.
|
|
[20]
|
贾磊, 等. CD34和Ki67的表达预测肝癌术后复发的风险[J]. 肝脏, 2020, 25(2): 197-199.
|
|
[21]
|
王凝芳, 等. Ki-67在肝细胞肝癌中的表达及其临床意义[J]. 大连大学学报, 2003(2): 71-73+79.
|
|
[22]
|
孙树刚, 等. 肝细胞癌E-cadherin和ki-67蛋白表达与肝切除术预后关系的研究[J]. 中国现代普通外科进展, 2010, 13(2): 125-128.
|
|
[23]
|
张景丽, 等. 乳腺癌Ki-67及PCNA表达的比较研究[J]. 临床与实验病理学杂志, 2003(1): 70-72.
|
|
[24]
|
Imamura, H., et al. (2003) Risk Factors Contributing to Early and Late Phase Intrahepatic Recurrence of Hepatocellular Carcinoma after Hepatectomy. Journal of Hepatology, 38, 200-207. [Google Scholar] [CrossRef]
|